[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343810-105":59,"doc-detail-343810-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","modification-and-validation-of-the-system-causability-scale-using-ai-based-therapeutic-recommendations-for-urological-cancer-patients-a-basis-for-the-development-of-a-prospective-comparative-study","Modification and Validation of the System Causability Scale Using AI-Based Therapeutic Recommendations for Urological Cancer Patients - A Basis for the Development of a Prospective Comparative Study","","The work examines how artificial intelligence, especially large language models, can strengthen therapeutic decision-making in clinical oncology for urological cancers, where direct evidence remains limited. It validates both the System Causability Scale (SCS) and a modified version (mSCS), and selects LLMs using recommendations from ChatGPT-4 and a multidisciplinary tumor board across 40 scenarios. Results show strong validity, reliability, and internal consistency, with mSCS outperforming on clinical applicability. Delphi processes define tested LLMs and a non-inferiority margin for the upcoming CONCORDIA trial.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/modification-and-validation-of-the-system-causability-scale-using-ai-based-therapeutic-recommendations-for-urological-cancer-patients-a-basis-for-the-development-of-a-prospective-comparative-study/343810/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/modification-and-validation-of-the-system-causability-scale-using-ai-based-therapeutic-recommendations-for-urological-cancer-patients-a-basis-for-the-development-of-a-prospective-comparative-study/343810.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in urological cancer care?","Question",{"text":112,"@type":113},"It addresses the lack of evidence on whether large language model–based treatment recommendations can support clinical oncology decision-making specifically for urological cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What tools did the study validate?",{"text":117,"@type":113},"The study validated the System Causability Scale (SCS) and a modified version (mSCS), including their reliability, validity, and internal consistency.",{"name":119,"@type":110,"acceptedAnswer":120},"How were large language models and the comparison standard chosen for the CONCORDIA trial?",{"text":121,"@type":113},"Two Delphi processes selected the LLMs to be tested (ChatGPT-4 and Claude 3.5 Sonnet) and established the acceptable non-inferiority margin versus multidisciplinary tumor board recommendations.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343810,1790940110,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nModification and Validation of the System Causability Scale Using AI-Based Therapeutic Recommendations for Urological Cancer Patients: A Basis for the Development of a Prospective Comparative Study  \nEmily Rinderknecht 1, Dominik von Winning 2, Anton Kravchuk 2, Christof Schäfer 3, Marco J. Schnabel 1, Stephan Siepmann 2, Roman Mayr 1, Jochen Grassinger 4, Christopher Goßler 1, Fabian Pohl 5, Peter J. Siska 6, Florian Zeman 7, Johannes Breyer 1, Anna Schmelzer 2, Christian Gilfrich 2, Sabine D. Brookman-May 8, Maximilian Burger 1, Maximilian Haas 1,† and Matthias May 2, *,†  \nCitation: Rinderknecht, E.; von Winning, D.; Kravchuk, A.; Schäfer, C.; Schnabel, M.J.; Siepmann, S.; Mayr, R.; Grassinger, J.; Goßler, C.; Pohl, F.; et al. Modification and Validation of the System Causability Scale Using  \nAI-Based Therapeutic Recommendations for Urological Cancer Patients: A Basis for the Development of a Prospective Comparative Study. Curr. Oncol. 2024, 31, 7061–7073. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/curroncol31110520](10.3390/curroncol31110520)  \nReceived: 14 October 2024  \nRevised: 5 November 2024  \nAccepted: 9 November 2024  \nPublished: 11 November 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Urology, Caritas St. Josef Hospital, University of Regensburg,93053 Regensburg, Germany; erinderknecht@csj.de (E.R.); mschnabel@csj.de (M.J.S.); rmayr@csj.de (R.M.); cgossler@csj.de (C.G.); [jbreyer@csj.de](jbreyer@csj.de) (J.B.); [mburger@caritasstjosef.de](mburger@caritasstjosef.de) (M.B.); [mhaas@csj.de](mhaas@csj.de) (M.H.)  \n2 Department of Urology, St. Elisabeth Hospital Straubing, 94315 Straubing, Germany; [dominik.vonwinning@klinikum-straubing.de](dominik.vonwinning@klinikum-straubing.de) (D.v.W.); [anton.kravchuk@klinikum-straubing.de](anton.kravchuk@klinikum-straubing.de) (A.K.); [stephan.siepmann@klinikum-straubing.de](stephan.siepmann@klinikum-straubing.de) (S.S.); [anna.schmelzer01@stud.uni-goettingen.de](anna.schmelzer01@stud.uni-goettingen.de) (A.S.); [christian.gilfrich@klinikum-straubing.de](christian.gilfrich@klinikum-straubing.de) (C.G.)  \n3 Department of Radiotherapy, Straubing Hospital Medical Care Centre, 94315 Straubing, Germany; [christof.schaefermbm@mvz-klinikum-straubing.de](christof.schaefermbm@mvz-klinikum-straubing.de)  \n4 Department of Hematology and Oncology, Straubing Hospital Medical Care Centre,  \n94315 Straubing, Germany; [jochen.grassinger@mvz-klinikum-straubing.de](jochen.grassinger@mvz-klinikum-straubing.de)  \n5 Department of Radiotherapy, University Hospital Regensburg, 93053 Regensburg, Germany; [fabian.pohl@ukr.de](fabian.pohl@ukr.de)  \n6 Department of Internal Medicine III, University Hospital Regensburg, 93053 Regensburg, Germany; [peter.siska@klinik.uni-regensburg.de](peter.siska@klinik.uni-regensburg.de)  \n7 Center for Clinical Studies, University Hospital Regensburg, 93053 Regensburg, Germany; [florian.zeman@klinik.uni-regensburg.de](florian.zeman@klinik.uni-regensburg.de)  \n8 Department of Urology, Ludwig-Maximilians-University (LMU), 80539 Munich, Germany; [sabine.brookman-may@email.de](sabine.brookman-may@email.de)  \n* Correspondence: matthias.may@klinikum-straubing.de † Shared senior author position.  \nAbstract: The integration of artificial intelligence, particularly Large Language Models (LLMs), has the potential to significantly enhance therapeutic decision-making in clinical oncology. Initial studies across various disciplines have demonstrated that LLM-based treatment recommendations can rival those of multidisciplinary tumor boards (MTBs); however, such data are currently lacking for urological cancers. This prepar","cbCaibeAZZVsxHnU","https://ap.wps.com/l/cbCaibeAZZVsxHnU","pdf",270333,13,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What problem does the study address in urological cancer care?\",\"answer\":\"It addresses the lack of evidence on whether large language model–based treatment recommendations can support clinical oncology decision-making specifically for urological cancers.\"},{\"question\":\"What tools did the study validate?\",\"answer\":\"The study validated the System Causability Scale (SCS) and a modified version (mSCS), including their reliability, validity, and internal consistency.\"},{\"question\":\"How were large language models and the comparison standard chosen for the CONCORDIA trial?\",\"answer\":\"Two Delphi processes selected the LLMs to be tested (ChatGPT-4 and Claude 3.5 Sonnet) and established the acceptable non-inferiority margin versus multidisciplinary tumor board recommendations.\"}]","Modification and Validation of the System Causability Scale Using AI-Based Therapeutic Recommendations for Urological Cancer Patients - A Basis for the Development of a Prospective Comparative Study | PDF",1790052204,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bb42737cc27ec19872024e9e6c8b3b5.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c3e5cdc593158cffefa173f16677983.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebb5b23fad03a5183260b1f5f8d1eb40.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0c74a599441445288d05dd65db5718b.webp",980,1385]